Tanajak, P., Pongkan, W., Chattipakorn, S. C., & Chattipakorn, N. (2018). Increased plasma FGF21 level as an early biomarker for insulin resistance and metabolic disturbance in obese insulin-resistant rats.
Chicago Style CitationTanajak, Pongpan, Wanpitak Pongkan, Siriporn C. Chattipakorn, and Nipon Chattipakorn. Increased Plasma FGF21 Level As an Early Biomarker for Insulin Resistance and Metabolic Disturbance in Obese Insulin-resistant Rats. 2018.
MLA引文Tanajak, Pongpan, Wanpitak Pongkan, Siriporn C. Chattipakorn, and Nipon Chattipakorn. Increased Plasma FGF21 Level As an Early Biomarker for Insulin Resistance and Metabolic Disturbance in Obese Insulin-resistant Rats. 2018.
警告：這些引文格式不一定是100％准確.